186 related articles for article (PubMed ID: 32178550)
1. Advances in quantitative immunohistochemistry and their contribution to breast cancer.
Yaghoobi V; Martinez-Morilla S; Liu Y; Charette L; Rimm DL; Harigopal M
Expert Rev Mol Diagn; 2020 May; 20(5):509-522. PubMed ID: 32178550
[No Abstract] [Full Text] [Related]
2. Combining fluorescence-based image segmentation and automated microfluidics for ultrafast cell-by-cell assessment of biomarkers for HER2-type breast carcinoma.
Migliozzi D; Nguyen HT; Gijs MAM
J Biomed Opt; 2018 Nov; 24(2):1-8. PubMed ID: 30484294
[TBL] [Abstract][Full Text] [Related]
3. A novel, automated technology for multiplex biomarker imaging and application to breast cancer.
Clarke GM; Zubovits JT; Shaikh KA; Wang D; Dinn SR; Corwin AD; Santamaria-Pang A; Li Q; Nofech-Mozes S; Liu K; Pang Z; Filkins RJ; Yaffe MJ
Histopathology; 2014 Jan; 64(2):242-55. PubMed ID: 24330149
[TBL] [Abstract][Full Text] [Related]
4. Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms.
Peck AR; Girondo MA; Liu C; Kovatich AJ; Hooke JA; Shriver CD; Hu H; Mitchell EP; Freydin B; Hyslop T; Chervoneva I; Rui H
Mod Pathol; 2016 Oct; 29(10):1143-54. PubMed ID: 27312066
[TBL] [Abstract][Full Text] [Related]
5. Multispectral Fluorescence Imaging Allows for Distinctive Topographic Assessment and Subclassification of Tumor-Infiltrating and Surrounding Immune Cells.
Wickenhauser C; Bethmann D; Feng Z; Jensen SM; Ballesteros-Merino C; Massa C; Steven A; Bauer M; Kaatzsch P; Pazaitis N; Toma G; Bifulco CB; Fox BA; Seliger B
Methods Mol Biol; 2019; 1913():13-31. PubMed ID: 30666596
[TBL] [Abstract][Full Text] [Related]
6. Digital pathology and image analysis in tissue biomarker research.
Hamilton PW; Bankhead P; Wang Y; Hutchinson R; Kieran D; McArt DG; James J; Salto-Tellez M
Methods; 2014 Nov; 70(1):59-73. PubMed ID: 25034370
[TBL] [Abstract][Full Text] [Related]
7. An automated staining protocol for seven-colour immunofluorescence of human tissue sections for diagnostic and prognostic use.
Lim JCT; Yeong JPS; Lim CJ; Ong CCH; Wong SC; Chew VSP; Ahmed SS; Tan PH; Iqbal J
Pathology; 2018 Apr; 50(3):333-341. PubMed ID: 29429740
[TBL] [Abstract][Full Text] [Related]
8. Toponostics of invasive ductal breast carcinoma: combination of spatial protein expression imaging and quantitative proteome signature analysis.
Röwer C; Ziems B; Radtke A; Schmitt O; Reimer T; Koy C; Thiesen HJ; Gerber B; Glocker MO
Int J Clin Exp Pathol; 2011 Mar; 4(5):454-67. PubMed ID: 21738817
[TBL] [Abstract][Full Text] [Related]
9. Double Immunohistochemistry and Digital Image Analysis.
Moreno-Ruiz P; Wik Leiss L; Mezheyeuski A; Ehnman M
Methods Mol Biol; 2019; 1913():3-11. PubMed ID: 30666595
[TBL] [Abstract][Full Text] [Related]
10. Multiplex Immunohistochemistry for Mapping the Tumor Microenvironment.
Kalra J; Baker J
Methods Mol Biol; 2017; 1554():237-251. PubMed ID: 28185197
[TBL] [Abstract][Full Text] [Related]
11. Impact of tissue sampling on accuracy of Ki67 immunohistochemistry evaluation in breast cancer.
Besusparis J; Plancoulaine B; Rasmusson A; Augulis R; Green AR; Ellis IO; Laurinaviciene A; Herlin P; Laurinavicius A
Diagn Pathol; 2016 Aug; 11(1):82. PubMed ID: 27576949
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Analysis of a Multiplexed Immunofluorescence Panel in T-Cell Lymphoma.
Ng SB; Fan S; Choo SN; Hoppe M; Mai Phuong H; De Mel S; Jeyasekharan AD
SLAS Technol; 2018 Jun; 23(3):252-258. PubMed ID: 29241019
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer.
McLaughlin J; Han G; Schalper KA; Carvajal-Hausdorf D; Pelekanou V; Rehman J; Velcheti V; Herbst R; LoRusso P; Rimm DL
JAMA Oncol; 2016 Jan; 2(1):46-54. PubMed ID: 26562159
[TBL] [Abstract][Full Text] [Related]
14. Advances in tissue-based imaging: impact on oncology research and clinical practice.
Rahman A; Jahangir C; Lynch SM; Alattar N; Aura C; Russell N; Lanigan F; Gallagher WM
Expert Rev Mol Diagn; 2020 Oct; 20(10):1027-1037. PubMed ID: 32510287
[TBL] [Abstract][Full Text] [Related]
15. Optimisation of multiplex immunofluorescence for a non-spectral fluorescence scanning system.
Anyaegbu CC; Lee-Pullen TF; Miller TJ; Abel TN; Platell CF; McCoy MJ
J Immunol Methods; 2019 Sep; 472():25-34. PubMed ID: 31181211
[TBL] [Abstract][Full Text] [Related]
16. Comparison of breast cancer surrogate subtyping using a closed-system RT-qPCR breast cancer assay and immunohistochemistry on 100 core needle biopsies with matching surgical specimens.
Janeva S; Parris TZ; Nasic S; De Lara S; Larsson K; Audisio RA; Olofsson Bagge R; Kovács A
BMC Cancer; 2021 Apr; 21(1):439. PubMed ID: 33879115
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry Microarrays.
Li H; Brewer G; Ongo G; Normandeau F; Omeroglu A; Juncker D
Anal Chem; 2017 Sep; 89(17):8620-8625. PubMed ID: 28763195
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Significance of Novel Proteins in Breast Cancer Using Tissue Microarray Technology.
Mulrane L; Gallagher WM; O'Connor DP
Methods Mol Biol; 2017; 1501():311-325. PubMed ID: 27796961
[TBL] [Abstract][Full Text] [Related]
19. Automatic tumor-stroma separation in fluorescence TMAs enables the quantitative high-throughput analysis of multiple cancer biomarkers.
Lahrmann B; Halama N; Sinn HP; Schirmacher P; Jaeger D; Grabe N
PLoS One; 2011; 6(12):e28048. PubMed ID: 22164226
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of reverse phase protein array for molecular classification of breast cancer.
Negm OH; Muftah AA; Aleskandarany MA; Hamed MR; Ahmad DA; Nolan CC; Diez-Rodriguez M; Tighe PJ; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2016 Jan; 155(1):25-35. PubMed ID: 26661092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
